Strategies for determining HLA compatibility in related donor bone marrow transplantation

Transplantation

Volumn 64, Issue 6, 1997, Pages 828-835

  Zachary, Andrea A ^a,c   Vogelsang, Georgia B ^a   Steinberg, Arthur G ^b   Leffell, Mary S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Immunogenetics Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN;

ALGORITHM; ANTIGEN ANTIBODY COMPLEX; ANTIGENICITY; ARTICLE; BONE MARROW TRANSPLANTATION; COST EFFECTIVENESS ANALYSIS; GENOTYPE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PHENOTYPE; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALGORITHMS; ALLELES; BONE MARROW TRANSPLANTATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; LIVING DONORS; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, GENETIC; MODELS, IMMUNOLOGICAL; NUCLEAR FAMILY; UNITED STATES;

EID: 0030798538     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709270-00007     Document Type: Article

References (13)

1. Beatty PC, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765.
2. Hansen JA, Mickelson EM, Beatty PG, Thomas ED. Clinical bone marrow transplantation: donor selection and recipient monitoring. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology, 3rd ed. Washington, DC: ASM, 1986: 892.
3. Charlton RK. Testing for bone marrow and blood component compatibility. In: Tardif GN, MacQueen JM, eds. Tissue typing reference manual. Richmond, VA: SEOPF, 1993: A.7-1.
4. Hurley CK. DNA-based typing of HLA for transplantation. In: Leffell MS, Donnenberg AD, Rose NR, eds. Handbook of human immunology. Boca Raton, FL: CRC Press, 1997: 521.
5. Chao N, Schmidt G, Niland J, et al. Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft versus host disease. N Engl J Med 1993; 329: 1225.
6. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
7. Zachary AA, Steinberg AG, Bias WB, Leffell MS. The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry. Transplantation 1996; 62: 272.
8. Hopkins KA. The basic lymphocyte microcytotoxicity tests. In: Phelan DL, Mickelson EM, Noreen HS, Cluff DM, Nikaein A, eds. ASHI laboratory manual, 3rd ed. Lenexa, KS: ASHI, 1994: I.B.1.1.
9. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225.
10. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, Vol. 1. Oxford, UK: Oxford University Press, 1992: 397.
11. Leffell MS, Steinberg AG, Bias WB, Machan CH, Zachary AA. The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. Transplantation 1994; 58: 1119.
12. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990; 323: 1818.
13. Hegland J, Ng J, Hurley CK, et al. Pilot project to evaluate quality of large scale HLA-A, B and DR typing of bone marrow donors. Hum Immunol 1995; 44 (suppl 1): 126.